ARTICLE | Company News
ImClone deal
February 1, 1993 8:00 AM UTC
ImClone Systems Inc. IMCL and Chugai Pharmaceutical Co. Ltd. have agreed to develop blood cell growth factors that target the FLK-2 receptor, found on cells believed to be totipotent stem cells. IMCL...